BRIEF published on 07/18/2024 at 19:10, 2 years ago Ikonisys finalise une augmentation de capital de 250 000 € via un placement privé Placement Privé Augmentation De Capital Ressources Financières Détection Du Cancer Ikonisys
PRESS RELEASE published on 07/18/2024 at 19:05, 2 years ago Inside Information / Operations of the issuer (acquisitions, sales...) Ikonisys completed a €250k capital increase through a private placement with CC Holding Srl to strengthen financial resources for commercial development Private Placement Capital Increase Financial Resources Ikonisys Commercial Development
PRESS RELEASE published on 07/18/2024 at 19:05, 2 years ago Informations privilégiées / Opérations de l'émetteur (acquisitions, cessions...) Ikonisys finalise une augmentation de capital de 250 K€ via un placement privé avec CC Holding Srl pour renforcer ses ressources financières et son développement commercial Placement Privé Augmentation De Capital Développement Commercial Ikonisys CC Holding Srl
BRIEF published on 06/11/2024 at 18:35, 2 years 2 months ago Ikonisys et Ulisse Biomed nouent un partenariat stratégique pour le diagnostic du cancer Innovation Biotechnologie Partenariat Diagnostic Cancer
BRIEF published on 06/11/2024 at 18:35, 2 years 2 months ago Ikonisys and Ulisse Biomed enter into a strategic partnership for cancer diagnosis Innovation Biotechnology Partnership Diagnostic Cancer
PRESS RELEASE published on 06/11/2024 at 18:30, 2 years 2 months ago Informations privilégiées / Autres communiqués Ikonisys et Ulisse Biomed annoncent un partenariat stratégique pour soutenir l'innovation dans le domaine du diagnostic du cancer Innovation Partenariat Stratégique Ikonisys Diagnostic Du Cancer Ulisse Biomed
PRESS RELEASE published on 06/11/2024 at 18:30, 2 years 2 months ago Inside Information / Other news releases Ikonisys and Ulisse Biomed announce strategic partnership to enhance cancer diagnostics through technical and commercial collaboration, aiming to provide innovative solutions and maximize market penetration Innovation Strategic Partnership Cancer Diagnostics Ikonisys Ulisse Biomed
BRIEF published on 06/03/2024 at 21:04, 2 years 2 months ago Ikonisys Completes Capital Increase to Boost Commercial Expansion Private Placement Capital Increase Commercial Expansion Ikonisys Hospitex Integration
BRIEF published on 06/03/2024 at 21:04, 2 years 2 months ago Ikonisys finalise une augmentation de capital pour stimuler son expansion commerciale Placement Privé Augmentation De Capital Expansion Commerciale Ikonisys Intégration Hospitex
PRESS RELEASE published on 06/03/2024 at 20:59, 2 years 2 months ago Inside Information / Other news releases Ikonisys announces €150k capital increase through private placement to accelerate commercial development. New funds strengthen financial resources for expansion Private Placement Capital Increase Financial Resources Ikonisys Commercial Development
Published on 08/12/2026 at 23:30, 48 minutes ago CCL Industries Announces Record Results for 2026 Second Quarter
Published on 08/12/2026 at 23:30, 48 minutes ago Bolt Metals to Rebrand as 26 Metals Inc. and Adopt the Ticker "IRON," Highlighting Its Focus on Flagship Florália Iron Project in Brazil's Iron Quadrangle
Published on 08/12/2026 at 23:20, 58 minutes ago RJK Explorations Ltd. Announces Upsize of Previously Announced Private Placement
Published on 08/12/2026 at 23:05, 1 hour 13 minutes ago Vox Royalty Reports Q2 2026 Results And Declares Quarterly Dividend
Published on 08/12/2026 at 22:01, 2 hours 17 minutes ago Fermi Names Lee McIntire as Chief Executive Officer
Published on 08/12/2026 at 21:05, 3 hours 13 minutes ago Aurisco Pharmaceutical is the First Generic Oligonucleotide Manufacturer in the World successfully inspected by USFDA
Published on 08/12/2026 at 19:57, 4 hours 20 minutes ago EQS-Adhoc: Hypoport SE: Hypoport SE resolves share buyback programme with a volume of up to EUR 10 million
Published on 08/12/2026 at 19:37, 4 hours 40 minutes ago EQS-Adhoc: Brockhaus Technologies AG: Preliminary revenue for H1 2026 at €13.4 million and adjusted EBITDA at €-0.5 million; forecast for the continuing operations unchanged
Published on 08/11/2026 at 17:45, 1 day 6 hours ago DAMARTEX / Droits de vote bruts et réels au 31 juillet 2026
Published on 08/11/2026 at 17:40, 1 day 6 hours ago Infotel : Déclaration des transactions sur actions propres réalisées du 3 au 7 août 2026 dans le cadre du programme de rachat d’actions
Published on 08/10/2026 at 18:00, 2 days 6 hours ago AXA: Information relating to the number of voting rights and shares making up the share capital on 31/07/2026
Published on 08/10/2026 at 18:00, 2 days 6 hours ago AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/07/2026
